Sagis’ molecular diagnostic laboratory employs state-of-the-art technologies, innovative techniques, and validated processes for the most advanced diagnostic and clinical genetic testing. Our molecular assays deliver comprehensive diagnostic, therapeutic, as well as prognostic information to partnering physicians and patients.
We also utilize multiplexed nanoscale qPCR technology to accurately identify pathogens, typically within 24-48 hours. The results generated in our laboratory are crucial for making rapid diagnoses, ensuring accurate outcomes, and suggesting personalized treatment plans.
Molecular Testing Services
Urinary Tract Pathogen Panel (UrinsightTM)
We provide accurate and comprehensive PCR assays to detect a wide range of UTI pathogens (UrinsightTM Panel). In addition, our UrinsightTM plus test covers selective antimicrobial resistance genes to help clinicians better target therapies to reduce the use of broad therapeutic regimens that contribute to the growing threat of antibiotic resistance.
Respiratory Tract Pathogen Panel
Various pathogens, including RNA and DNA viruses and bacteria, cause upper and lower respiratory tract infections. Coinfections are also a growing concern that requires broad and effective pathogen detection. Traditional detection methods, such as culture or immunoassay-based methods, have limitations.
However, Sagis offers a multiplexed test that can determine if the patient is currently infected with SARS-CoV-2, influenza A/B, and/or the respiratory syncytial virus (RSV).
Nail Fungus Panel
Diagnostic panel testing for onychomycosis is crucial to helping identify nail deformation pathology and determining a proper treatment plan. Because psoriasis and malignant melanoma conditions can mirror the appearance of fungal infections, accurate and rapid diagnoses are essential to ordering the right treatment plan.
Sagis offers prompt and accurate testing of onychomycosis (nail fungus) by utilizing advanced molecular identification techniques along with Periodic acid-Schiff (PAS) and Grocott methenamine-silver (GMS) staining.
Wound Care Molecular Insight Panel
Lastly, Sagis’ wound care panel identifies which type(s) of bacteria are causing infection and recommends the best antibiotic treatment options. Our molecular unit simultaneously screens wounds for antibiotic resistance markers and pathogens, utilizing advanced molecular identification techniques.